INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

18,684 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$262K
2,160 sh
Apr 22, 2026Apr 24, 2026
Page 262 of 468
← PrevNext →

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUY
traded Apr 22, 2026
+2d
SEC Form 4

Evidence

29
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$501K
535 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

29
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$544K
581 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

28
RA
Reid Jeffrey A.EVP, Chief HR Officer
BOKFBOK FINANCIAL CORP
Open-market sale
SELL$148K
1,095 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
540 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

25
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$82K
2,754 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

21
RA
Reid Jeffrey A.EVP, Chief HR Officer
BOKFBOK FINANCIAL CORP
Open-market sale
SELL$14K
105 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$269K
19.1K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

14
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$205K
2,281 sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

11
HC
Hamilton James CChief Medical Officer
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$750K
10.0K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

9
MC
McDonough ClaireChief Financial Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$184K
10.2K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

6
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$144K
40.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$267K
19.1K sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$262K
19.1K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$29K
10.0K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$31K
10.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
5,250 sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.43M
12.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

43
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Open-market sale
SELL$2.11M
23.4K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

41
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$388K
3,255 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

41
DN
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Open-market sale
SELL$89K
345.9K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.66M
49.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.83M
15.5K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.57M
22.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
PM
Peterson MichaelEXECUTIVE VICE PRESIDENT
SEICSEI INVESTMENTS CO
Open-market sale
SELL$900K
10.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

39
PL
Patrick Deval LDirector
TOSTToast, Inc.
Open-market sale
SELL$62K
1,667 sh
Jan 9, 2025Apr 23, 2026
traded Jan 9, 2025
+469dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$10.51M
90.9K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

35
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Open-market sale
SELL$5.27M
1.50M sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
350 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

34
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Open-market sale
SELL$18K
69.8K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

33
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$620K
5,404 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.39M
28.8K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.65M
22.4K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.15M
10.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4.78M
41.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$721K
6,045 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

29
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Open-market sale
SELL$141K
1,559 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
650 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

26
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
9,100 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

25
YA
Yoshiyama AnnieSVP, Finance
ALLOAllogene Therapeutics, Inc.
Open-market sale
SELL$22K
9,586 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

UPBDUPBOUND GROUP, INC.Nov 2 – Nov 3
7 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K